Vitamin D and renal outcome: the fourth outcome of CKD-MBD? Oshima Award Address 2015.

about

Vitamin D and renal outcome: the fourth outcome of CKD-MBD? Oshima Award Address 2015.

Item

http://www.wikidata.org/entity/Q48263079

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Vitamin D and renal outcome: the fourth outcome of CKD-MBD? Oshima Award Address 2015.

@en

Vitamin D and renal outcome: the fourth outcome of CKD-MBD? Oshima Award Address 2015.

@nl

type

Item

label

Vitamin D and renal outcome: the fourth outcome of CKD-MBD? Oshima Award Address 2015.

@en

Vitamin D and renal outcome: the fourth outcome of CKD-MBD? Oshima Award Address 2015.

@nl

prefLabel

Vitamin D and renal outcome: the fourth outcome of CKD-MBD? Oshima Award Address 2015.

@en

Vitamin D and renal outcome: the fourth outcome of CKD-MBD? Oshima Award Address 2015.

@nl

P1476

Vitamin D and renal outcome: the fourth outcome of CKD-MBD? Oshima Award Address 2015

@en

P2093

Takayuki Hamano

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

FGF23 signaling impairs neutrophil recruitment and host defense during CKD.

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

The parathyroid is a target organ for FGF23 in rats

Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein.

Fibroblast growth factor 23 and 25-hydroxyvitamin D levels are associated with estimated glomerular filtration rate decline.

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury.

Vitamin D regulating TGF-β induced epithelial-mesenchymal transition

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.

P2888

s10157-017-1517-3

P304

249-256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S10157-017-1517-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Takayuki Hamano

P5008

ScienceSource

P577

2017-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29270765

http://www.w3.org/2001/XMLSchema#string

P921

vitamin D

chronic kidney disease-mineral and bone disorder

P932

5838134

http://www.w3.org/2001/XMLSchema#string